Launch of On-Site Influenza Vaccination Service by JS Medical Holdings
Overview
JS Medical Holdings, headquartered in Minato, Tokyo, has announced the introduction of an on-site influenza vaccination service for businesses and organizations in the Tokyo metropolitan area. Set to begin accepting applications for the 2025 fiscal year, this initiative aims to enhance infection control measures at workplaces, provide efficient vaccination options, and contribute to business continuity planning (BCP).
Understanding Influenza Vaccination
Influenza vaccinations work by introducing inactivated pathogens (like viruses and bacteria) into the body to prepare the immune system and reduce the likelihood of contracting the disease. Conducting these vaccinations consistently across an organization significantly improves overall immunity and helps prevent secondary infections among employees. Typically, antibody formation occurs approximately two weeks after vaccination, with the antibodies maintaining effectiveness for about five months.
Increased Risks and Workplace Preparedness
Recent years have seen a rise in overseas travel and an increased risk of seasonal influenza outbreaks occurring earlier than in previous years. While vaccine supply remains stable, the time and effort required to book appointments with external medical facilities often leads to lower participation rates for employees. JS Medical Holdings addresses this issue with their on-site service, ensuring that vaccination becomes a more accessible option for all employees.
Key Features of the On-Site Vaccination Service
- - Increased Participation: By creating a comfortable environment for employees to receive vaccinations on-site, companies can see higher engagement with health initiatives they promote.
- - Cost Reduction: Companies can save on travel costs due to the convenience of in-office vaccination, and several employees can be vaccinated efficiently in a short time frame, minimizing the impact on work hours.
- - Business Continuity Planning (BCP): By facilitating group vaccinations for over a specific number of employees, organizations can achieve herd immunity, contributing positively to their business continuity plans during health crises.
The Vaccination Process
1.
Site Assessment: The space required for vaccinations will be pre-checked. Online meetings are available for this purpose.
2.
Scheduling: Companies can coordinate with JS Medical Holdings to finalize the date for vaccinations.
3.
Pre-Notification: Notification documents for employees will be provided, simplifying communication about the vaccination process.
4.
Participant Count: Organizations will collect information on employees interested in vaccination.
5.
Detail Communication: Relevant details of the vaccination process will be assembled, and schedules announced to participants.
6.
Execution: Authorized physicians and nurses will visit the company to administer the vaccines.
7.
Billing: Invoices will be issued later based on the number of people vaccinated.
Service Details
- - Implementation: Medical professionals from partnered healthcare institutions will perform vaccinations at the workplace.
- - Areas Covered: Tokyo, Kanagawa, Saitama, and Chiba.
- - Number of Participants: Vaccinations can accommodate over 50 individuals in one session, with the capacity to serve 50–100 people within one hour.
- - Pricing: Costs will vary based on region and number of participants.
Application Process
- - Start of Applications: Applications will open in September 2025.
- - Eligibility: Corporations or organizations with more than 50 individuals wishing to be vaccinated by December 2025 are encouraged to apply.
Contact Information
For more details, potential clients can reach JS Medical Holdings at:
- - Address: 7F AY Building, 3-2-2 Kita-Aoyama, Minato-ku, Tokyo 107-0061
- - Phone: 03-5357-7289 (Weekdays 9:00 - 18:00)
- - Email: [email protected] – Please mention “Influenza Vaccination Inquiry” for inquiries.
- - Website: https://jsmhd.com/